文献速递关节外科

椎管内麻醉下全髋或全膝关节置换术后恶心呕吐风险:比较常规止吐药联合或不联合EmeTerm腕带的随机试验

Risk of Postoperative Nausea and Vomiting After Total Hip or Knee Arthroplasty Under Spinal Anesthesia: Randomized Trial Comparing Conventional Antiemetics with or without the EmeTerm Bracelet.
PubMed 文献 · J Bone Joint Surg Am · 2025-03-28

该随机试验纳入195例全髋关节置换和153例全膝关节置换的术后恶心呕吐中高风险患者,比较单用常规止吐药(地塞米松和昂丹司琼)与联合EmeTerm经皮穴位电刺激腕带的效果。联合腕带组术后24小时内恶心呕吐发生率为16.0%,低于单用止吐药组的31.2%(p=0.001),并降低了严重恶心呕吐和止吐补救率,改善了恢复质量评分。

要点

  • 联合EmeTerm腕带组术后24小时恶心呕吐发生率为16.0%,单用止吐药组为31.2%(p=0.001)。
  • 联合腕带组严重恶心呕吐发生率为1.1%,单用止吐药组为8.1%(p=0.002)。
  • 联合腕带组止吐补救率为3.4%,单用止吐药组为13.9%(p=0.001)。

核心结论

  • EmeTerm腕带增强了止吐药在椎管内麻醉下全髋和全膝关节置换术后减少恶心呕吐的疗效,并可能改善短期恢复。

研究设计与样本

  • 随机对照试验,纳入术后恶心呕吐中高风险的195例全髋关节置换和153例全膝关节置换患者,随机分为单用常规止吐药(地塞米松和昂丹司琼)组或联合EmeTerm腕带组。

主要发现

  • 联合腕带组术后24小时内恶心呕吐发生率为16.0%,单用止吐药组为31.2%(p=0.001)。
  • 联合腕带组严重恶心呕吐发生率为1.1%,单用止吐药组为8.1%(p=0.002)。
  • 联合腕带组止吐补救率为3.4%,单用止吐药组为13.9%(p=0.001)。
  • 使用腕带使术后24小时内恶心呕吐风险降低61%(校正风险比0.39;95%CI 0.24至0.63),获益在术后0至3小时和3至6小时间隔变得显著。
  • 联合腕带组完全缓解率为84.0%,单用止吐药组为68.8%(p=0.001),且联合腕带组24小时恢复质量评分更好。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acupoint stimulation has been shown to reduce the risk of postoperative nausea and vomiting (PONV) after various types of surgeries involving general anesthesia, but whether the same is true after orthopaedic surgery involving spinal anesthesia is unclear. The purpose of this study was to compare PONV rates and the quality of recovery between patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA) under spinal anesthesia receiving conventional antiemetics alone and those receiving antiemetics combined with use of a transcutaneous electrical acupoint stimulation bracelet (EmeTerm; WAT Medical Enterprise). METHODS: Patients at moderate or high risk for PONV, including 195 patients undergoing THA and 153 patients undergoing TKA, were randomized to receive routine antiemetics (dexamethasone and ondansetron) alone or with use of the EmeTerm bracelet. The primary outcome was the PONV incidence within 24 hours postoperatively; secondary outcomes included the rates of severe PONV, antiemetic rescue, adverse events, and Quality of Recovery scores. RESULTS: Combining antiemetics with the EmeTerm bracelet significantly reduced PONV (16.0% compared with 31.2%; p = 0.001), severe PONV (1.1% compared with 8.1%; p = 0.002), and antiemetic rescue (3.4% compared with 13.9%; p = 0.001). Use of the bracelet reduced the risk of PONV within 24 hours by 61% (adjusted hazard ratio, 0.39; 95% confidence interval [CI], 0.24 to 0.63), and its benefit became significant at 0 to 3 and 3 to 6-hour intervals after surgery. The complete response rate was higher for the bracelet + antiemetics group compared with the group with antiemetics alone (84.0% compared with 68.8%; p = 0.001), with better Quality of Recovery scores at 24 hours in the bracelet + antiemetics group. CONCLUSIONS: The EmeTerm bracelet enhanced the efficacy of antiemetics in reducing PONV after THA and TKA under spinal anesthesia and may improve short-term recovery. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Yang Y, Wang C, Cao G, et al. Risk of Postoperative Nausea and Vomiting After Total Hip or Knee Arthroplasty Under Spinal Anesthesia: Randomized Trial Comparing Conventional Antiemetics with or without the EmeTerm Bracelet. J Bone Joint Surg Am. 2025. PMID: 40153477. doi:10.2106/JBJS.24.00773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。